Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer

E. N. Knyazev; K. A. Fomicheva; D. S. Mikhailenko; K. M. Nyushko; T. R. Samatov; B. Ya. Alekseev; M. Yu. Shkurnikov

doi:10.1007/s10517-016-3357-7

Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer

Autores: Knyazev E.N.¹, Fomicheva K.A.², Mikhailenko D.S.², Nyushko K.M.², Samatov T.R.¹, Alekseev B.Y.², Shkurnikov M.Y.¹^,2
Afiliações:
1. BioClinicum Center Research and Development Company
2. Medical Radiology Center
Edição: Volume 161, Nº 1 (2016)
Páginas: 108-111
Seção: Article
URL: https://journals.rcsi.science/0007-4888/article/view/237158
DOI: https://doi.org/10.1007/s10517-016-3357-7
ID: 237158

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Somente assinantes

Resumo
Sobre autores
Bibliografia
Arquivos suplementares
Estatísticas

Resumo

Peripheral blood plasma profiles of circulating microRNA expression were analyzed in patients with prostatic cancer and benign hyperplasia. In prostatic cancer, significant increase in hsa-miR-619-5p and hsa-miR-1184 microRNA expression and significant decrease in hsalet-7b-5p and hsa-let-7c-5p microRNA expression were observed. The role of the relationship between the microRNA expression and the activities and functions of host genes with introns encoding these microRNA is discussed.